CN121794754A - 信息处理装置、信息处理装置的运行方法及信息处理装置的运行程序 - Google Patents
信息处理装置、信息处理装置的运行方法及信息处理装置的运行程序Info
- Publication number
- CN121794754A CN121794754A CN202480055463.XA CN202480055463A CN121794754A CN 121794754 A CN121794754 A CN 121794754A CN 202480055463 A CN202480055463 A CN 202480055463A CN 121794754 A CN121794754 A CN 121794754A
- Authority
- CN
- China
- Prior art keywords
- information
- amino acid
- information processing
- acid sequence
- processing apparatus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/20—Protein or domain folding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Biophysics (AREA)
- Data Mining & Analysis (AREA)
- Artificial Intelligence (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Chemical & Material Sciences (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023-167582 | 2023-09-28 | ||
| JP2023167582 | 2023-09-28 | ||
| PCT/JP2024/032771 WO2025070104A1 (ja) | 2023-09-28 | 2024-09-12 | 情報処理装置、情報処理装置の作動方法、および情報処理装置の作動プログラム |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN121794754A true CN121794754A (zh) | 2026-04-03 |
Family
ID=95204085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202480055463.XA Pending CN121794754A (zh) | 2023-09-28 | 2024-09-12 | 信息处理装置、信息处理装置的运行方法及信息处理装置的运行程序 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20260196292A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4760727A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2025070104A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN121794754A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2025070104A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7236253B2 (ja) * | 2018-11-07 | 2023-03-09 | 合同会社H.U.グループ中央研究所 | 情報処理方法および学習モデル |
| US20220157403A1 (en) * | 2019-04-09 | 2022-05-19 | Eth Zurich | Systems and methods to classify antibodies |
| JP2021158973A (ja) | 2020-03-31 | 2021-10-11 | 株式会社豊田中央研究所 | 変異体の熱的安定性を予測するためのモデル及びその利用 |
-
2024
- 2024-09-12 JP JP2025548767A patent/JPWO2025070104A1/ja active Pending
- 2024-09-12 EP EP24871899.1A patent/EP4760727A1/en active Pending
- 2024-09-12 CN CN202480055463.XA patent/CN121794754A/zh active Pending
- 2024-09-12 WO PCT/JP2024/032771 patent/WO2025070104A1/ja not_active Ceased
-
2026
- 2026-02-26 US US19/551,423 patent/US20260196292A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2025070104A1 (cg-RX-API-DMAC7.html) | 2025-04-03 |
| WO2025070104A1 (ja) | 2025-04-03 |
| US20260196292A1 (en) | 2026-07-09 |
| EP4760727A1 (en) | 2026-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Piccoli et al. | 2019 White paper on recent issues in bioanalysis: FDA immunogenicity guidance, gene therapy, critical reagents, biomarkers and flow cytometry validation (part 3–recommendations on 2019 FDA immunogenicity guidance, gene therapy bioanalytical challenges, strategies for critical reagent management, biomarker assay validation, flow cytometry validation & CLSI H62) | |
| Chinery et al. | Paragraph—antibody paratope prediction using graph neural networks with minimal feature vectors | |
| Whitelegg et al. | WAM: an improved algorithm for modelling antibodies on the WEB | |
| Choi et al. | Predicting antibody complementarity determining region structures without classification | |
| Weitzner et al. | Accurate structure prediction of CDR H3 loops enabled by a novel structure-based C-terminal constraint | |
| Horvath et al. | The TeGenero incident and the Duff Report conclusions: a series of unfortunate events or an avoidable event? | |
| Goel et al. | Biosimilars in rheumatology: understanding the rigor of their development | |
| Kurki et al. | Biosimilar regulation in the EU | |
| Thrift et al. | Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity | |
| Quarmby et al. | MAPPs for the identification of immunogenic hotspots of biotherapeutics; an overview of the technology and its application to the biopharmaceutical arena | |
| Nishigami et al. | Revisiting antibody modeling assessment for CDR-H3 loop | |
| Shakhnovich et al. | Immunogenicity in clinical practice and drug development: when is it significant? | |
| Barnett et al. | Seroprevalence of measles, rubella, and varicella in refugees | |
| Pelkmans et al. | Antibodies against domain I of β2-glycoprotein I: the one and only? | |
| US20250068803A1 (en) | Pharmaceutical support device, operation method of pharmaceutical support device, and operation program of pharmaceutical support device | |
| Sheridan | Pharma consolidates its grip on post-antibody landscape. | |
| Sullivan et al. | Analytic characterization of biosimilars | |
| Clarke et al. | Patients with core antibody positive and surface antigen negative hepatitis B (anti-HBc+, HBsAg−) on anti-TNF therapy have a low rate of reactivation | |
| Asor et al. | Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition | |
| Herling et al. | Nonspecificity fingerprints for clinical-stage antibodies in solution | |
| Gilep et al. | Improving AlphaFold 3 structural modeling by incorporating explicit crosslinks | |
| Tickle et al. | High-throughput screening for high affinity antibodies | |
| Carrasco-Triguero | Insights on the immunogenicity of antibody–drug conjugates | |
| Brown et al. | De-risking clinical trial failure through mechanistic simulation | |
| Perry et al. | The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |